Skip to content

Lifeline Endocardial Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K792168

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK792168 Date13 Nov 1979ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lifeline Endocardial Pacing Lead is a Permanent Pacemaker Electrode (product code DTB), designed to deliver electrical stimulation directly to the heart muscle. It is intended for use in cardiac pacing systems to regulate heart rate in patients with bradycardia or conduction disorders.

This device is supplied sterile and intended for single-use implantation within the endocardium. It is classified as a Class III medical device under FDA regulations (870.3680) and was granted FDA 510(k) clearance (K792168) in 1979. Compatible with MRI environments as per manufacturer specifications, it is distributed in sterile packaging for surgical use.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Lifeline Endocardial Pacing Lead primarily used for in clinical practice?

    The Lifeline Endocardial Pacing Lead is designed to deliver electrical stimulation directly to the heart muscle as part of a cardiac pacing system. It is intended for patients with bradycardia (slow heart rate) or conduction disorders, helping to regulate their heart rhythm by ensuring consistent electrical impulses.

  • Is the Lifeline Endocardial Pacing Lead intended for reuse, or is it meant to be implanted once and discarded?

    The device is supplied sterile and explicitly intended for single-use implantation within the endocardium. Once implanted, it is not designed for removal or reuse, adhering to standard sterile surgical practices for permanent pacemaker electrodes.

  • How is the Lifeline Endocardial Pacing Lead packaged for surgical use, and what does that imply for handling?

    The lead is distributed in sterile packaging, ensuring it remains uncontaminated until ready for implantation. This packaging is designed for surgical environments, meaning it must be opened aseptically under sterile conditions to maintain sterility before use.

  • Can this device be used in patients who require MRI scans, and what considerations should be made?

    Yes, the Lifeline Endocardial Pacing Lead is compatible with MRI environments according to the manufacturer’s specifications. However, MRI use must follow strict protocols to avoid interference or complications, such as adhering to MRI-safe positioning and field strength guidelines to ensure patient safety.

  • What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its classification?

    The Lifeline Endocardial Pacing Lead underwent a Traditional 510(k) review through the FDA’s Cardiovascular (CV) advisory committee, with a decision of Substantially Equivalent (SE) to a predicate device. It is classified as a Class III medical device (870.3680), reflecting its role in life-sustaining or supporting functions, which requires rigorous pre-market clearance.